Status:
NOT_YET_RECRUITING
Introduction of Dispersible 3HP Formulations for TB Preventive Treatment in Children: a Multi-country Evaluation
Lead Sponsor:
The Aurum Institute NPC
Collaborating Sponsors:
Johns Hopkins University
KNCV Tuberculosis Foundation
Conditions:
TB - Tuberculosis
Household Contact
Eligibility:
All Genders
Brief Summary
The WHO has recommended TB preventive therapy (TPT) for children living with HIV (CLHIV) and household contacts of people living with TB, however, the scale-up and implementation of TPT has been sub-o...
Eligibility Criteria
Inclusion
- Clinic record review
- Medical records of children \<12 years who are either CLHIV or who are household contacts of people with pulmonary TB and who are initiated on TPT
Exclusion
- Records will be excluded for children who are contacts of a drug-resistant, have presumptive TB disease or are currently on TB treatment
- Qualitative study
- Inclusion Criteria:
- Adult caregiver (\>18 years) of a child \<12 years of age who is eligible for TPT
- Healthcare worker from one of the clinics in which the study will be conducted who sees outpatient pediatric consultations including TB-exposed children
- Policy maker or program manager who manages or is involved in PMTCT, TB and/or pediatric programming
Key Trial Info
Start Date :
August 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2025
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT06511180
Start Date
August 1 2024
End Date
June 1 2025
Last Update
July 19 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.